FDA product code JPA: System, Multipurpose For In Vitro Coagulation Studies
JPA is the FDA product code for system, multipurpose for in vitro coagulation studies. It is a Class II device, regulated under 21 CFR 864.5425 and reviewed by the Hematology panel. FDA has cleared 182 510(k) submissions under JPA, 10 in the last five years, from 68 different applicants. The average 510(k) review took 119 days (median 81); 165 days on average over the last three years. FDA has posted 44 recalls for JPA devices, 7 initiated in the last five years.
Classification
| Field | Value |
|---|---|
| Device name | System, Multipurpose For In Vitro Coagulation Studies |
| Device class | Class II |
| Regulation | 21 CFR 864.5425 |
| Review panel | HE — Hematology |
| Medical specialty | Hematology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for JPA
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 4 | 171 |
| 2018 | 1 | 219 |
| 2019 | 3 | 152 |
| 2021 | 1 | 518 |
| 2022 | 1 | 767 |
| 2023 | 3 | 410 |
| 2024 | 1 | 266 |
| 2025 | 3 | 40 |
| 2026 | 2 | 190 |
Compare with all 510(k) review times · Search every JPA clearance
Top JPA applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Bio/Data Corp. | 13 | 1989-06-23 |
| Dade Behring, Inc. | 12 | 2003-01-16 |
| Instrumentation Laboratory CO | 11 | 2023-09-29 |
| International Technidyne Corp. | 9 | 2005-02-10 |
| Helena Laboratories | 8 | 2006-05-10 |
63 more applicants have JPA clearances. See the full list in Caduvo.
Most recent JPA clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K260909 | Sienco, Inc. | Sonoclot Coagulation & Platelet Function Analyzer System with Sonoclot Viewer (SCP1); Sonoclot Coagulation & Platelet Function Analzyer System with Sonoclot Viewer (SCP2); Sonoclot Coagulation Analyzer System with Sonoclot Viewer (SC1) | 2026-10-27 | 222 |
| K253658 | Diagnostica Stago, Inc. | STA Satellite Max® | 2026-04-27 | 158 |
| K250965 | Sysmex America, Inc. | Automated Blood Coagulation Analyzer CN-Series (CN-6000) | 2025-06-02 | 63 |
| K251024 | Haemonetics | TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge | 2025-04-30 | 28 |
| K243858 | Haemonetics Corporation | TEG 6s Hemostasis System Citrated: K, KH, RT, FF Assay Cartridge | 2025-01-15 | 30 |
Recalls for JPA devices
44 product recalls in 32 recall events; 7 initiated in the last five years and 6 still open. Most recent: 2026-09-14.
| Year | Recalls |
|---|---|
| 2019 | 3 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2025 | 1 |
| 2026 | 1 |
Frequently asked questions
What is FDA product code JPA?
JPA is the FDA product code for system, multipurpose for in vitro coagulation studies. It is a Class II device, regulated under 21 CFR 864.5425 and reviewed by the Hematology panel.
What device class is JPA?
Class II, regulation 21 CFR 864.5425. Typical premarket route: 510(k).
How long does a 510(k) take for product code JPA?
Across 182 cleared submissions the average was 119 days from receipt to decision (median 81).
Which companies have the most JPA clearances?
Bio/Data Corp. (13); Dade Behring, Inc. (12); Instrumentation Laboratory CO (11); International Technidyne Corp. (9); Helena Laboratories (8).
Have JPA devices been recalled?
Yes: 44 product recalls across 32 recall events; the most recent began 2026-09-14.
Next steps
- Run an FDA pathway report with predicate devices for product code JPA
- Run a recall and safety report across every JPA manufacturer
- Watch product code JPA for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Hematology product codes · FDA product code lookup · 510(k) database search · 510(k) review times